Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

NCT05301894 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Epileptic Encephalopathy
Continuous Spike and Wave During Sleep

Interventions

DRUG: NBI-827104

Sponsor

Neurocrine Biosciences